Erratum: FGF16 promotes invasive behavior of SKOV-3 ovarian cancer cells through activation of mitogen-activated protein kinase (MAPK) signaling pathway (J. Biol. Chem. (2014) 289 (1415–1428) DOI: 10.1074/jbc.M113.535427);FGF16 promotes invasive behavior of SKOV-3 ovarian cancer cells through activation of mitogen-activated protein kinase (MAPK) signaling pathway

Journal of Biological Chemistry

Volumn 289, Issue 3, 2014, Pages 1415-1428

  Basu, Moitri ^a   Mukhopadhyay, Satinath ^b   Chatterjee, Uttara ^b   Roy, Sib Sankar ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; CHEMICAL ACTIVATION; CYTOLOGY; DISEASES; T-CELLS; TRANSCRIPTION; TUMORS;

ADENOCARCINOMA CELLS; BINDING PARTNERS; HOMEODOMAIN TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; OVARIAN CANCER CELLS; SIGNALING PATHWAYS; TARGET GENE EXPRESSION; THERAPEUTIC STRATEGY;

CELL SIGNALING;

BETA CATENIN; CADHERIN; CADHERIN 1; FIBROBLAST GROWTH FACTOR 16; GELATINASE A; GELATINASE B; LYMPHOID ENHANCER FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SNAI1; TRANSCRIPTION FACTOR PITX2; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; CDH1 PROTEIN, HUMAN; FGF16 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; HOMEODOMAIN PROTEIN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TUMOR PROTEIN; WNT PROTEIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION; WNT SIGNALING PATHWAY; ADENOCARCINOMA; BIOSYNTHESIS; CLINICAL TRIAL; GENETICS; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

ADENOCARCINOMA; BETA CATENIN; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 84892638930     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.W120.016735     Document Type: Erratum

References (53)

1. Yap, T. A., Carden, C. P., and Kaye, S. B. (2009) Beyond chemotherapy. Targeted therapies in ovarian cancer. Nat. Rev. Cancer 9, 167-181
2. Powers, C. J., McLeskey, S. W., and Wellstein, A. (2000) Fibroblast growth factors, their receptors, and signalling. Endocr. Relat. Cancer 7, 165-197
3. Böttcher, R. T., and Niehrs, C. (2005) Fibroblast growth factor signaling during early vertebrate development. Endocr. Rev. 26, 63-77 (Pubitemid 40209387)
4. Turner, N., and Grose, R. (2010) Fibroblast growth factor signalling. From development to cancer. Nat. Rev. Cancer 10, 116-129
5. Birrer, M. J., Johnson, M. E., Hao, K., Wong, K. K., Park, D. C., Bell, A., Welch, W. R., Berkowitz, R. S., and Mok, S. C. (2007) Whole genome oligonucleotide based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advancedstage serous ovarian adenocarcinomas. J. Clin. Oncol. 25, 2281-2287 (Pubitemid 46954656)
6. Marek, L., Ware, K. E., Fritzsche, A., Hercule, P., Helton, W. R., Smith, J. E., McDermott, L. A., Coldren, C. D., Nemenoff, R. A., Merrick, D. T., Helfrich, B. A., Bunn, P. A., Jr., and Heasley, L. E. (2009) Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in nonsmall-cell lung cancer cells. Mol. Pharmacol. 75, 196-207
7. Giri, D., Ropiquet, F., and Ittmann, M. (1999) Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin. Cancer Res. 5, 1063-1071 (Pubitemid 29233220)
8. Ropiquet, F., Giri, D., Kwabi-Addo, B., Mansukhani, A., and Ittmann, M. (2000) Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. Cancer Res. 60, 4245-4250 (Pubitemid 30636612)
9. Itoh, N. (2007) The Fgf families in humans, mice, and zebrafish. Their evolutional processes and roles in development, metabolism, and disease. Biol. Pharm. Bull. 30, 1819-1825 (Pubitemid 47607758)
10. Chamorro, M. N., Schwartz, D. R., Vonica, A., Brivanlou, A. H., Cho, K. R., and Varmus, H. E. (2005) FGF-20 and DKK1 are transcriptional targets of β-catenin and FGF-20 is implicated in cancer and development. EMBO J. 24, 73-84 (Pubitemid 40188465)
11. Hendrix, N.D, Wu, R., Kuick, R., Schwartz, D.R., Fearon, E.R., and Cho, K.R. (2006) Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 66, 1354-1362 (Pubitemid 43259914)
12. Ornitz, D.M., and Itoh, N. (2001) Fibroblast growth factors. Genome Biology 2, reviews3005
13. Miyake, A., Konishi, M., Martin, F. H., Hernday, N. A., Ozaki, K., Yamamoto, S., Mikami, T., Arakawa, T., and Itoh, N. (1998) Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. Biochem. Biophys. Res. Commun. 243, 148-152 (Pubitemid 28414206)
14. Konishi, M., Mikami, T., Yamasaki, M., Miyake, A., and Itoh, N. (2000) Fibroblast growth factor-16 is a growth factor for embryonic brown adipocytes. J. Biol. Chem. 275, 12119-12122 (Pubitemid 30237788)
15. Nomura, R., Kamei, E., Hotta, Y., Konishi, M., Miyake, A., and Itoh, N. (2006) Fgf16 is essential for pectoral fin bud formation in zebrafish. Biochem. Biophys. Res. Commun. 347, 340-346 (Pubitemid 44015682)
16. Antoine, M., Wirz, W., Tag, C. G, Gressner, A. M., Wycislo, M., Müller, R., and Kiefer, P. (2006) Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation. Biochem. Biophys. Res. Commun. 346, 224-233 (Pubitemid 43865988)
17. Lavine, K. J., Yu, K., White, A.C., Zhang, X., Smith, C., Partanen, J., and Ornitz, D. M. (2005) Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev. Cell 8, 85-95 (Pubitemid 40058008)
18. Lavine, K. J., White, A. C., Park, C., Smith, C. S., Choi, K., Long, F., Hui, C. C., and Ornitz, D. M. (2006) Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development. Genes Dev. 20, 1651-1666 (Pubitemid 43901103)
19. Lin, C.R., Kioussi, C., O'Connell, S., Briata, P., Szeto, D., Liu, F., Izpisúa-Belmonte, J.C., and Rosenfeld, M.G. (1999) Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 401, 279-282
20. Ai, D., Wang, J., Amen, M., Lu, M. F., Amendt, B. A., and Martin, J. F. (2007) Nuclear factor 1 and T-cell factor/LEF recognition elements regulate PITX2 transcription in pituitary development. Mol. Cell. Biol. 27, 5765-5775 (Pubitemid 47257832)
21. Cox, C. J., Espinoza, H. M., McWilliams, B., Chappell, K., Morton, L., Hjalt, T. A., Semina, E. V., and Amendt, B. A. (2002) Differential regulation of gene expression by PITX2 isoforms. J. Biol. Chem. 277, 25001-25010 (Pubitemid 34951803)
22. Nimmrich, I., Sieuwerts, A. M., Meijer-van Gelder, M. E., Schwope, I., Bolt-de Vries, J., Harbeck, N., Koenig, T., Hartmann, O., Kluth, A., Dietrich, D., Magdolen, V., Portengen, H., Look, M.P., Klijn, J. G., Lesche, R., Schmitt, M., Maier, S., Foekens, J. A., and Martens, J. W. (2008) DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. Breast Cancer Res. Treat 111, 429-437
23. Hirose, H., Ishii, H., Mimori, K., Tanaka, F., Takemasa, I., Mizushima, T., Ikeda, M., Yamamoto, H., Sekimoto, M., Doki, Y., and Mori, M. (2011) The significance of PITX2 overexpression in human colorectal cancer. Ann. Surg. Oncol. 18, 3005-3012
24. Rask, K., Nilsson, A., Brännström, M., Carlsson, P., Hellberg, P., Janson, P.O., Hedin, L., and Sundfeldt, K. (2003) Wnt-signalling pathway in ovarian epithelial tumours. Increased expression of β-catenin and GSK3β. Br. J. Cancer 89, 1298-1304 (Pubitemid 37363420)
25. Barbolina, M. V., Burkhalter, R. J., and Stack, M. S. (2011) Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment. Biochem. J. 437, 1-12
26. Basu, M., and Roy, S. S. (2013) Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3. J. Biol. Chem. 288, 4355-4367
27. Saha, S. K., Ghosh, P., Konar, A., Bhattacharya, S., and Roy, S.S. (2005) Differential expression of procollagen lysine 2-oxoglutarate 5-deoxygenase and matrix metalloproteinase isoforms in hypothyroid rat ovary and disintegration of extracellular matrix. Endocrinology 146, 2963-2975 (Pubitemid 41002803)
28. Ghosh, S., Basu, M., and Roy, S. S. (2012) ETS-1 regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell SKOV-3. J. Biol. Chem. 287, 15001-15015
29. Nandi, S. S., Ghosh, P., and Roy, S. S. (2011) Expression of PITX2 homeodomain transcription factor during rat gonadal development in a sexually dimorphic manner. Cell Physiol. Biochem. 27, 159-170
30. Dailey, L., Ambrosetti, D., Mansukhani, A., and Basilico, C. (2005) Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 16, 233-247 (Pubitemid 40616120)
31. Tsang, M., and Dawid, I. B. (2004) Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci. STKE 2004, pe17
32. Peters, K. G., Marie, J., Wilson, E., Ives, H. E., Escobedo, J., Del Rosario, M., Mirda, D., and Williams, L. T. (1992) Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2 flux but not mitogenesis. Nature 358, 678-681
33. Klint, P., and Claesson-Welsh, L. (1999) Signal transduction by fibroblast growth factor receptors. Front. Biosci. 4, D165 D177
34. Johnson, D. E., and Williams, L. T. (1993) Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-41
35. Cole, C., Lau, S., Backen, A., Clamp, A., Rushton, G., Dive, C., Hodgkinson, C., McVey, R., Kitchener, H., and Jayson, G. C. (2010) Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer. Cancer Biol. Ther. 10, 495-504
36. Steele, I. A., Edmondson, R. J., Bulmer, J. N., Bolger, B. S., Leung, H. Y., and Davies, B. R. (2001) Induction of FGF receptor 2-IIIb expression and response to its ligands in epithelial ovarian cancer. Oncogene 20, 5878-5887 (Pubitemid 32937957)
37. Mohammadi, M., Froum, S., Hamby, J. M., Schroeder, M. C., Panek, R. L., Lu, G. H., Eliseenkova, A. V., Green, D., Schlessinger, J., and Hubbard, S. R. (1998) Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J. 17, 5896-5904 (Pubitemid 28474784)
38. Koziczak, M., Holbro, T., and Hynes, N.E. (2004) Blocking of FGFR signaling inhibits breast cancer cell proliferation through down-regulation of D-type cyclins. Oncogene 23, 3501-3508 (Pubitemid 38658416)
39. Hudson, L. G., Zeineldin, R., and Stack, M. S. (2008) Phenotypic plasticity of neoplastic ovarian epithelium. Unique cadherin profiles in tumor progression. Clin. Exp. Metastasis 25, 643-655
40. Veatch, A. L., Carson, L. F., and Ramakrishnan, S. (1994) Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int. J. Cancer. 58, 393-399 (Pubitemid 24254650)
41. Daraï, E., Scoazec, J.Y., Walker-Combrouze, F., Mlika-Cabanne, N., Feldmann, G., Madelenat, P., and Potet, F. (1997) Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors. A clinicopathologic study of 60 cases. Hum. Pathol. 28, 922-928 (Pubitemid 27355552)
42. Peinado, H., Olmeda, D., and Cano, A. (2007) Snail, Zeb and bHLH factors in tumour progression. An alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415-428 (Pubitemid 46809165)
43. Shields, M.A., Dangi-Garimella, S., Krantz, S.B., Bentrem, D.J., and Munshi, H.G. (2011) Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase- dependent collagen invasion. J. Biol. Chem. 286, 10495-10504
44. Ota, I., Li, X.Y., Hu, Y., and Weiss, S.J. (2009) Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc. Natl. Acad. Sci. 106, 20318-20323
45. Miyoshi, A., Kitajima, Y., Sumi, K., Sato, K., Hagiwara, A., Koga, Y., and Miyazaki, K. (2004) Snail and SIP1 increase cancer invasion by up-regulating MMP family in hepatocellular carcinoma cells. Br. J. Cancer 90, 1265-1273 (Pubitemid 38496823)
46. Birkedal-Hansen, H., Moore, W. G., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J. A. (1993) Matrix metalloproteinases. A review. Crit. Rev. Oral. Biol. Med. 4, 197-250
47. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., and Quaranta, V. (1997) Induction of cell migration by matrix metalloprotease- 2 cleavage of laminin-5. Science 277, 225-228 (Pubitemid 27446075)
48. Kioussi, C., Briata, P., Baek, S. H., Rose, D. W., Hamblet, N. S., Herman, T., Ohgi, K. A., Lin, C., Gleiberman, A., Wang, J., Brault, V., Ruiz-Lozano, P., Nguyen, H. D., Kemler, R., Glass, C. K., Wynshaw-Boris, A., and Rosenfeld, M. G. (2002) Identification of a Wnt/Dvl/β-catenin PITX2 pathway mediating cell type-specific proliferation during development. Cell 111, 673-685 (Pubitemid 35441249)
49. Roose, J., and Clevers, H. (1999) TCF transcription factors. Molecular switches in carcinogenesis. Biochim Biophys. Acta 1424, M23 M37 (Pubitemid 29488713)
50. Lu, S. Y., Sontag, D. P., Detillieux, K. A., and Cattini, P. A. (2008) FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling. A possible role in postnatal development. Am. J. Physiol. Cell Physiol. 294, C1242 C1249
51. Kratochwil, K., Galceran, J., Tontsch, S., Roth, W., and Grosschedl, R. (2002) FGF4, a direct target of LEF1 and Wnt signaling, can rescue the arrest of tooth organogenesis in Lef1-/- mice. Genes Dev. 16, 3173-3185 (Pubitemid 36025971)
52. Shimokawa, T., Furukawa, Y., Sakai, M., Li, M., Miwa, N., Lin, Y. M., and Nakamura, Y. (2003) Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the β-catenin/T-cell factor complex. Cancer Res. 63, 6116-6120 (Pubitemid 37255147)
53. Vadlamudi, U., Espinoza, H. M., Ganga, M., Martin, D. M., Liu, X., Engelhardt, J. F., and Amendt, B. A. (2005) PITX2,β-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J. Cell Sci. 118, 1129-1137 (Pubitemid 40528684)